Nakao Ishida
About
In The Last Decade
Nakao Ishida
298 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Molecular Biology 2.1k
- Epidemiology 1.6k
- Infectious Diseases 1.2k
- Immunology 978
- Organic Chemistry 865
Countries citing papers authored by Nakao Ishida
This map shows the geographic impact of Nakao Ishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nakao Ishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nakao Ishida more than expected).
Fields of papers citing papers by Nakao Ishida
This network shows the impact of papers produced by Nakao Ishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nakao Ishida. The network helps show where Nakao Ishida may publish in the future.
Co-authorship network of co-authors of Nakao Ishida
This figure shows the co-authorship network connecting the top 25 collaborators of Nakao Ishida. A scholar is included among the top collaborators of Nakao Ishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nakao Ishida. Nakao Ishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 30 | |
| 5 | 2 | |
| 6 | 7 | |
| 7 | 1 | |
| 8 | Inhibition of ligand-independent cap formation of mouse lymphocytes and Raji cells by neocarzinostatin. | 4 |
| 9 | Modification of fetal immune system by maternal anti-DNA antibody. I. Enhanced immune response to DNA in the mice exposed to anti-DNA antibody early in life. | 13 |
| 10 | 5 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 2 | |
| 14 | 3 | |
| 15 | 1 | |
| 16 | 2 | |
| 17 | 15 | |
| 18 | 18 | |
| 19 | 14 | |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.